Matthew Silva to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Matthew Silva has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
0.664
-
Silva M, Matthews ML, Jarvis C, Nolan NM, Belliveau P, Malloy M, Gandhi P. Meta-analysis of drug-induced adverse events associated with intensive-dose statin therapy. Clin Ther. 2007 Feb; 29(2):253-60.
Score: 0.240
-
Silva MA, Swanson AC, Gandhi PJ, Tataronis GR. Statin-related adverse events: a meta-analysis. Clin Ther. 2006 Jan; 28(1):26-35.
Score: 0.222
-
Chan KY, Boucher ES, Gandhi PJ, Silva MA. HMG-CoA reductase inhibitors for lowering elevated levels of C-reactive protein. Am J Health Syst Pharm. 2004 Aug 15; 61(16):1676-81.
Score: 0.202